Modulation of cholinergic activity through lynx prototoxins: Implications for cognition and anxiety regulation

Kristin R. Anderson; Katie M. Hoffman; Julie M. Miwa

doi:10.1016/j.neuropharm.2020.108071

Modulation of cholinergic activity through lynx prototoxins: Implications for cognition and anxiety regulation

Kristin R. Anderson, Katie M. Hoffman, Julie M. Miwa

Lehigh University

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Original language	English
Article number	108071
Journal	Neuropharmacology
Volume	174
DOIs	https://doi.org/10.1016/j.neuropharm.2020.108071
State	Published - Sep 1 2020

Access to Document

10.1016/j.neuropharm.2020.108071

Cite this

@article{99368a4a031e4d0d85b04b81953521ce,

title = "Modulation of cholinergic activity through lynx prototoxins: Implications for cognition and anxiety regulation",

author = "Anderson, \{Kristin R.\} and Hoffman, \{Katie M.\} and Miwa, \{Julie M.\}",

note = "Funding Information: The work was supported by DA043567 and GM123131-01 for JMM and KRA and NSF BCS-1745823 for JMM and Lehigh University . Special thanks to Talulla Palumbo for editorial assistance, and the Lehigh University Biological Sciences Department for support. Declarations of interest: JMM is founder of Ophidion, Inc., a biotechnology company.",

year = "2020",

month = sep,

day = "1",

doi = "10.1016/j.neuropharm.2020.108071",

language = "English",

volume = "174",

journal = "Neuropharmacology",

issn = "0028-3908",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Modulation of cholinergic activity through lynx prototoxins

T2 - Implications for cognition and anxiety regulation

AU - Anderson, Kristin R.

AU - Hoffman, Katie M.

AU - Miwa, Julie M.

N1 - Funding Information: The work was supported by DA043567 and GM123131-01 for JMM and KRA and NSF BCS-1745823 for JMM and Lehigh University . Special thanks to Talulla Palumbo for editorial assistance, and the Lehigh University Biological Sciences Department for support. Declarations of interest: JMM is founder of Ophidion, Inc., a biotechnology company.

PY - 2020/9/1

Y1 - 2020/9/1

UR - https://www.scopus.com/pages/publications/85085769729

U2 - 10.1016/j.neuropharm.2020.108071

DO - 10.1016/j.neuropharm.2020.108071

M3 - Review article

C2 - 32298703

AN - SCOPUS:85085769729

SN - 0028-3908

VL - 174

JO - Neuropharmacology

JF - Neuropharmacology

M1 - 108071

ER -

Modulation of cholinergic activity through lynx prototoxins: Implications for cognition and anxiety regulation

Access to Document

Other files and links

Cite this